Bernard Omech
ID: UNCST-2020-R014820
|
Baseline characteristics and development of an integrated chronic disease care model for diabetes and hypertension management at primary healthcare facilities (ICDC)
REFNo: HS4285ES
To co-design an integrated chronic Diseases care model for management of hypertension and Diabetes mellitus through a participatory process to inform future intervention studies in Lango sub-region ,To examine the knowledge and practice of health care providers towards integration of chronic care for Hypertension and diabetes at selected PHC facilities in Lango sub-region ,To assess the patient’s perception of integration of chronic care for hypertension and diabetes mellitus among patients among patients attending selected primary health care facilities in Lango sub-region ,To determine baseline profiles (HBA1C levels, BP levels, QoL) of patients with hypertension and diabetes mellitus attending outpatient clinic at selected Primary health facilities in Lira City and District ,To evaluate baseline characteristics and develop a model of integrated chronic Disease care for management of hypertension and diabetes at primary health care in Lango Sub-region, Northern Uganda,
|
Uganda |
2024-07-02 12:56:36 |
2027-07-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Bruce Kirenga J
ID: UNCST-2019-R001460
|
INVENTORY, EFFECTIVENESS, AND SAFETY OF NOTIFIED NATURAL MEDICINES FOR THE TREATMENT OF DIABETES IN UGANDA: A PROSPECTIVE OBSERVATIONAL STUDY. A CONAT PROGRAM
REFNo: HS4356ES
The general objective is to create an inventory of NDA-notified natural or herbal medicines commonly used in the management of diabetes in adult patients in Uganda, and evaluate their preliminary effectiveness and safety
Specific objectives are:
1. To establish the NDA-notified natural or herbal medicines commonly used in the management of DM among adults in Uganda
2. To determine the preliminary effectiveness of the NDA-notified natural or herbal medicines in lowering blood glucose levels when used in isolation or as complementary to conventional DM medicines
3. To assess the effect of the NDA-notified natural or herbal medicines on specific cardiometabolic characteristics of adult patients with DM in Uganda, when used in isolation or as complementary to conventional DM medicine
4. To determine the safety profile of the NDA-notified natural or herbal medicines when used in isolation or as complementary to conventional DM medicine in adult patients in Uganda
|
Uganda |
2024-07-02 12:54:13 |
2027-07-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
DAVID KITYA
ID: UNCST-2022-R009620
|
ENHANCING PATIENT TRIAGE FOR NEUROSURGICAL CARE: A MIXED METHODS APPROACH
REFNo: HS4184ES
3. To design a patient triage model that accounts for criticality, resource availability, and healthcare costs.,2. To determine the key factors affecting patient triage decisions in neurosurgical care.,1. To assess the current patient triage system in neurosurgical care and identify its strengths and weaknesses.,The general objective of this research is to assess the current patient triage system in neurosurgical care, identifying its strengths and weaknesses in Uganda and Nigeria. ,
|
Uganda |
2024-07-02 12:52:48 |
2027-07-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Elliott Collins
ID: UNCST-2024-R005211
|
Measuring the Impact of Group Loans and Digitized Ledgers on Savings Group Participants in Uganda
REFNo: SS2731ES
Measure the impact of savings group ledger digitization on savings group efficiency, savings behavior, and social cohesion.,Measure the impact of FAST loans on savings group participants’ access to financial services and livelihood outcomes.,
|
USA |
2024-07-02 12:50:51 |
2027-07-02 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Juliet Mpendo
ID: UNCST-2024-R004147
|
Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and
HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition
REFNo: HS4092ES
• To describe new HIV infections in adult and adolescent participants at risk of HIV acquisition included in the HPTN 083 and HPTN 084 studies and their associated sub-studies.
Endpoints
• Number and characteristics of new HIV infections, including detection of resistance to CAB while on study. Secondary.
Secondary Objectives
• To describe any serious adverse events (SAEs), Grade 3 and Grade 4 ISRs, and AEs leading to withdrawal in adult and adolescent participants included in the HPTN 083 and HPTN 084 studies and their associated sub-studies.
Endpoints
• Incidence and severity of serious adverse events, Grade 3 and Grade 4 ISRs, and any clinical or laboratory adverse events leading to discontinuation of CAB while on study.
|
Uganda |
2024-07-02 12:49:10 |
2027-07-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|